UCB SA (UCB-BT)

QUOTE AND NEWS
FierceBiotech  Jul 23  Comment 
A new epilepsy treatment from Belgian drugmaker UCB helped reduce the rate of seizures in a Phase III trial, the company said, setting the stage for an FDA application and a shot at widening its footprint in the field.
Cloud Computing  Jul 7  Comment 
Infotrieve, Inc. (www.infotrieve.com), the leader in global-enterprise SaaS software and business services for scientific, technical and medical (“STM”) published content access and management, today announced that it has...
MedPage Today  Jun 19  Comment 
PARIS (MedPage Today) -- The benefits of treatment with certolizumab pegol (Cimzia) among patients with axial spondyloarthritis have persisted for 2 years, both for those with and without radiographic evidence of sacroiliitis, researchers reported...
newratings.com  May 21  Comment 
WILEX AG: WILEX returns rights from collaboration in oncology to UCB and UCB waives repayment of the shareholder loan WILEX AG / Key word(s): Agreement 21.05.2014 12:48 Dissemination of an Ad hoc announcement according to § 15 WpHG,...
Cloud Computing  May 7  Comment 
Catavolt, Inc., today announced the publication of a case study outlining UCB, Inc.'s success rapidly implementing Catavolt to solve a complex and challenging mobile workflow issue. The case study, entitled "UCB Improves Collaboration and...
FierceBiotech  May 1  Comment 
In this week's EuroBiotech Report, British trade unions and politicians are calling for guarantees that Pfizer won't perform its now-traditional post-takeover cuts in the event it succeeds in its pursuit of AstraZeneca, Ireland is worried that its...
The Hindu Business Line  Mar 27  Comment 
StemCyte India Therapeutics, a unit of StemCyte Inc., USA, will open more centres across India to collect umbilical cord blood (UCB) units and go for public banking of stem cells in a big way for...
FierceBiotech  Mar 11  Comment 
Sanofi is joining forces with UCB to study new small-molecule approaches to treating inflammatory conditions like arthritis, looking for an easier form of administration to some of the blockbuster injected biologics that dominate the field. The...
FiercePharma  Feb 20  Comment 
UCB is preparing for a changing of the guard. The Belgium-based drugmaker has tapped Jean-Christophe Tellier, who heads up its biopharma brands unit, to take over as CEO beginning next year, replacing current chief Roch Doliveux.





You may also be interested in articles related to UCB SA (UCB-BT):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki